Skip to content

Member

Carlo CICCIOLI

ECR · Italy

Group
ECR
Country
Italy
Roll-call participation
83.2 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
93.4 %ⓘ of 512 votes where the group had a line · ECR median 87.7 %
More facts (5)
National party
FdL FRATELLI D' ITALIA
In office
Since 16 Jul 2024
Against clear line
6 of 421 votesⓘ
Committees
ITRE (substitute), PECH (substitute), SANT (substitute), TRAN
Member id
257093
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

83.2 %

516 of 620 final votes while in office

ECR median: 91.9 % (−8.7 pts)

Chamber median: 90.6 %

With majority line ⓘ

93.4 %

478 of 512 votes where their group had a line

ECR median: 87.7 % (+5.7 pts)

Against clear line ⓘ

1.4 %

6 of 421 votes where their group had a clear line

4 opposite (for ↔ against), 2 abstained against the line

Abstention ⓘ

17.1 %

88 of 516 votes cast

Participation 83.2 % — ECR median 91.9 %, 79 members.ⓘ
Data as a table
Participation among the 79 members of the ECR with enough votes.
FigureParticipation
Carlo CICCIOLI83.2 %
ECR median91.9 %
Lowest in the group51.0 %
Highest in the group99.8 %
Members79
With majority line 93.4 % — ECR median 87.7 %, 79 members.ⓘ
Data as a table
With majority line among the 79 members of the ECR with enough votes.
FigureWith majority line
Carlo CICCIOLI93.4 %
ECR median87.7 %
Lowest in the group46.1 %
Highest in the group94.6 %
Members79
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of ECR; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: No vote recorded Majority line: Abstained
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: No vote recorded Majority line: Abstained
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: No vote recorded Majority line: Abstained
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: No vote recorded Majority line: For
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: Abstained ≠ groupMajority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 18 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within ECR

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Stefano CAVEDAGNA ECRItaly99 % of 4 329 shared81 %
Chiara GEMMA ECRItaly99 % of 4 773 shared81 %
Carlo FIDANZA ECRItaly99 % of 4 667 shared81 %
Alessandro CIRIANI ECRItaly99 % of 4 292 shared81 %
Francesco TORSELLI ECRItaly99 % of 4 769 shared81 %
Francesco VENTOLA ECRItaly99 % of 4 212 shared81 %
Mario MANTOVANI ECRItaly99 % of 3 597 shared81 %
Denis NESCI ECRItaly99 % of 4 822 shared81 %
Antonella SBERNA ECRItaly99 % of 4 218 shared81 %
Daniele POLATO ECRItaly99 % of 4 758 shared81 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Tiago MOREIRA DE SÁ PatriotsPortugal74 % of 4 622 shared68 %
Luis-Vicențiu LAZARUS No groupRomania73 % of 4 050 shared48 %
Nikola BARTŮŠEK changed group ECRCzechia73 % of 3 863 shared61 %
Juan Carlos GIRAUTA VIDAL PatriotsSpain73 % of 4 199 shared68 %
Jorge MARTÍN FRÍAS PatriotsSpain72 % of 3 789 shared68 %
Mireia BORRÁS PABÓN PatriotsSpain72 % of 4 471 shared68 %
Margarita DE LA PISA CARRIÓN PatriotsSpain72 % of 4 788 shared68 %
Jorge BUXADÉ VILLALBA PatriotsSpain71 % of 4 590 shared68 %
Antonín STANĚK PatriotsCzechia71 % of 3 197 shared68 %
Branko GRIMS changed group No groupSlovenia71 % of 4 551 shared50 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Industry, Research and EnergyITRE CommitteeSubstitute12 Feb 2025now
Committee on FisheriesPECH CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Committee on Transport and TourismTRAN CommitteeMember19 Jul 2024now
Delegation to the EU-Montenegro Stabilisation and Association Parliamentary CommitteeD-ME Joint parliamentary committeeVice-chair15 Jan 2025now
Delegation for relations with the Federative Republic of BrazilD-BR DelegationSubstitute19 Sept 2024now
Delegation to the Euro-Latin American Parliamentary AssemblyDLAT Parliamentary assemblyMember19 Sept 2024now
Intergroup on Biodiversity, Hunting and CountrysideIG10-04 Intergroup / working groupMember4 Feb 2025now
Intergroup on DemographyIG10-09 Intergroup / working groupMember27 Jan 2025now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now

Show all 13 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Role of sustainable fisheries and aquaculture in the Mediterranean blue economyShadow rapporteurPECH22 Apr 2026
Psychosocial risks, stress and mental health at workShadow rapporteur for an opinionSANT25 Mar 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteurITRE23 Mar 2026
EP delegation to the Conciliation Committee on Air Passenger Rights 2013/0072(COD)Trilogue negotiator12 Feb 2026
Circularity requirements for vehicle design and on management of end-of-life vehicles, amending Regulations (EU) 2018/858 and 2019/1020 and repealing Directives 2000/53/EC and 2005/64/ECShadow rapporteur for an opinionTRAN24 Mar 2025
ITRE Mission to Italy 24-26 February 2025Official delegation22 Jan 2025
The future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness.Shadow rapporteurITRE16 Jan 2025
No dossier namedShadow rapporteurTRAN4 Dec 2024
Fisheries management approaches for safeguarding sensitive species, tackling invasive species and benefitting local economies.Shadow rapporteurPECH4 Dec 2024
No dossier namedDelegation vice-chairD-ME25 Sept 2024

Show all 11 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

27 contributions recorded; 2 on behalf of their group; 38 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) Speech · 1 minRead
15 Sept 2026Escalation in the Middle East (debate) Speech · 1 minRead
9 Jul 2026Evaluation of the common fisheries policy and follow-up (debate) Speech · 2 minRead
8 Jul 2026The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan Speech · 1 minRead
29 Apr 2026Sudan’s abandoned humanitarian crisis: three years of conflict (debate) Speech · 1 minRead
29 Apr 2026Commission interference in democratic process and elections (topical debate) Speech · 1 minRead
11 Feb 2026Systemic oppression, inhumane conditions and arbitrary detentions by the regime in Iran Speech · 1 minRead
11 Feb 2026Addressing subcontracting chains and the role of intermediaries in order to protect workers’ rights (debate) Speech · 1 minRead
10 Feb 2026Situation in Northeast Syria, the violence against civilians and the need to maintain a sustainable ceasefire (debate) Speech · 1 minRead
22 Jan 2026Drones and new systems of warfare – the EU’s need to adapt to be fit for today’s security challenges (debate) Speech · 2 minRead

Show all 27 recent contributions

Questions and motions, 62

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
1 Sept 2026Paolo De Rosa’s links with the Autistici/Inventati hacker group and Italy’s Democratic Party P-10-2026-003407Priority written questionwith 20 co-authorsNot yet answered
9 Jul 2026Specific measures provided for in the Safe Hearts Plan to tackle obesity and promote the Mediterranean diet E-10-2026-002852Written questionwith 3 co-authors21 Aug 2026
6 Jul 2026MOTION FOR A RESOLUTION on the Threat of War Crimes, the Escalating Violations of International Humanitarian Law and the Human Rights Situation in El-Obeid, Sudan B-10-2026-0363Motion for a resolutionwith 15 co-authors—
1 Jul 2026MOTION FOR A RESOLUTION on the Commission delegated regulation (EU) of 27 March 2026 amending Delegated Regulation (EU) 2020/688 as regards infection with bluetongue virus (serotypes 1-24) and infection with epizootic haemorrhagic disease virus and introducing a derogation for movements of registered equine animals B-10-2026-0342Motion for a resolutionwith 40 co-authors—
1 Jul 2026The Erasmus+ ‘Spark’ project and the use of EU funds for sexual education programmes E-10-2026-002732Written questionwith 8 co-authors19 Aug 2026
30 Jun 2026Recent developments in Denmark concerning Islamic prayers in public spaces E-10-2026-002712Written questionwith 7 co-authors16 Sept 2026
26 Jun 2026External interference of Islamic fundamentalism in Europe E-10-2026-002652Written questionwith 9 co-authors18 Sept 2026
18 Jun 2026Inclusion of surrogacy in the new EU strategy to combat trafficking in human beings E-10-2026-002535Written questionwith 19 co-authors4 Aug 2026
18 Jun 2026Use of European Social Fund Plus resources to finance abortion, and the definition of healthcare E-10-2026-002536Written questionwith 16 co-authors24 Sept 2026
9 Jun 2026Implementation of Regulation (EU) 2023/1230 on machinery: shortcomings in the technical framework and risks to Europe’s industrial competitiveness E-10-2026-002354Written questionwith 5 co-authors6 Aug 2026

Show all 62 questions and motions

Amendments tabled in committee, 67

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
29 Sept 2026EU Emissions Trading System and market stability reserve: competitiveness and cost-effective decarbonisation ITRE-AM-796255 ITRE3
29 Sept 2026EU Emissions Trading System and market stability reserve: competitiveness and cost-effective decarbonisation ITRE-AM-796198 ITRE13
29 Sept 2026EU Emissions Trading System and market stability reserve: competitiveness and cost-effective decarbonisation ITRE-AM-796197 ITRE10
29 Sept 2026on the proposal for a directive of the European Parliament and of the Council amending Directive 2003/87/EC and Decision (EU) 2015/1814 as regards driving competitiveness and cost-effective decarbonisation ITRE-AM-796257 ITRE1
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ537
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5318
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ5313
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5352
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ5318
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ5313

Show all 67 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Italy National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
1 October 2026

Cite as

EU Parl Watch Research (2026). “Carlo CICCIOLI”. Member record. memberId 257093. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/257093?page=77&scope=final&vscope=all (retrieved 1 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/257093. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/257093?format=application%2Fld%2Bjson (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-257093,
  author = {{EU Parl Watch Research}},
  title = {{Carlo CICCIOLI}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/257093?page=77&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/257093?page=77&scope=final&vscope=all},
  urldate = {2026-10-01},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 257093. Official source: https://www.europarl.europa.eu/meps/en/257093. Data: EP Open Data: member record (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}